Cargando…
The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein
BACKGROUND: Basic studies of oncogenesis have demonstrated that either the elevated production of particular oncogene proteins or the occurrence of qualitative abnormalities in oncogenes can contribute to neoplastic cellular transformation. The purpose of our study was to identify an unique gene tha...
Autores principales: | Namkoong, Hong, Shin, Seung Min, Kim, Hyun Kee, Ha, Seon-Ah, Cho, Goang Won, Hur, Soo Young, Kim, Tae Eung, Kim, Jin Woo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1459871/ https://www.ncbi.nlm.nih.gov/pubmed/16545136 http://dx.doi.org/10.1186/1471-2407-6-74 |
Ejemplares similares
-
Niche formed by bone morphogenetic protein antagonists gremlin 1 and gremlin 2 in human hair follicles
por: Niiyama, Shiro, et al.
Publicado: (2022) -
Gremlin, a Bone Morphogenetic Protein Antagonist, Is a Crucial Angiogenic Factor in Pituitary Adenoma
por: Koketsu, Kenta, et al.
Publicado: (2015) -
HCCR-1, a novel oncogene, encodes a mitochondrial outer membrane protein and suppresses the UVC-induced apoptosis
por: Cho, Goang-Won, et al.
Publicado: (2007) -
Bone Morphogenetic Protein Antagonist Gremlin-1 Increases Myofibroblast Transition in Dermal Fibroblasts: Implications for Systemic Sclerosis
por: Duffy, Laura, et al.
Publicado: (2021) -
Gremlin-1 Induces BMP-Independent Tumor Cell Proliferation, Migration, and Invasion
por: Kim, Minsoo, et al.
Publicado: (2012)